Rabishield 100IU injection contain active components called Rabies human monoclonal antibodies.  One of the primary benefits of it is that it provides immediate passive immunity against the rabies virus. This is especially important in high-risk exposure situations where waiting for the body to generate its antibodies through vaccination may need to be faster. can be particularly advantageous for individuals with weakened or compromised immune systems, such as those with HIV/AIDS or those undergoing immunosuppressive treatments. By neutralizing the virus at the site of exposure, it can significantly reduce the risk of rabies infection, especially when administered promptly after a high-risk exposure, like a bite from a rabid animal. Some people may be hesitant to complete the full course of rabies vaccinations due to the number of required doses or the discomfort associated with injections. It can help improve compliance because they provides immediate protection, potentially reducing anxiety about rabies exposure. Rabishield 100IU injection may be contraindicated if a person has a known hypersensitivity or severe allergic reaction to any of its components. It should be avoided for low-risk exposure situations with minimal chances of rabies transmission. Its use during pregnancy and breastfeeding may be contraindicated due to limited study data, and potential risks and benefits should be carefully considered. It can be used in older individuals when indicated.  When indicated, Rabishield 100IU injection can be used in children as part of rabies post-exposure prophylaxis.